Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats

The SARS-CoV-2 pandemic have been affecting millions of people worldwide, since the beginning of 2020. COVID-19 can cause a wide range of clinical symptoms, which varies from asymptomatic presentation to severe respiratory insufficiency, exacerbation of immune response, disseminated microthrombosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Everidiene K. V. B., Bomfim, Camila G., Barbosa, Ana P., Noda, Paloma, Noronha, Irene L., Fernandes, Bianca H. V., Machado, Rafael R. G., Durigon, Edison L., Catanozi, Sergio, Rodrigues, Letícia G., Pieroni, Fabiana, Lima, Sérgio G., Teodoro, Walcy R., Queiroz, Zelita A. J., Silveira, Lizandre K. R., Charlie-Silva, Ives, Capelozzi, Vera L., Guzzo, Cristiane R., Fanelli, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129034/
https://www.ncbi.nlm.nih.gov/pubmed/35609032
http://dx.doi.org/10.1371/journal.pone.0268434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129034/
https://www.ncbi.nlm.nih.gov/pubmed/35609032
http://dx.doi.org/10.1371/journal.pone.0268434

Ejemplares similares